Bronchopulmonary dysplasia (BPD)

Lung x-ray Bronchopulmonary dysplasia (BPD)

Bronchopulmonary dysplasia (BPD)

Bronchopulmonary Dysplasia (BPD) is the most common chronic lung disease affecting low weight premature babies. If BPD takes hold in a newborn, there is no cure, and this condition can cause multiple severe life-long health complications.

One in 10 Australian babies is born premature, and up to 60 per cent of these develop BPD.

What is BPD?

What causes BPD?

How is BPD treated?

What are the long-term complications of BPD?

What are BPD symptoms?

Bronchopulmonary dysplasia (BPD) research at Hudson Institute

Hudson Institute scientists and clinician-scientists are at the forefront in investigating new treatments to prevent and treat premature babies with BPD.

New anti-inflammatory approaches for BPD

Associate Professor Claudia Nold and Professor Marcel Nold, Hudson Institute of Medical Research

Preventative treatment. Severe BPD causes considerable suffering for premature infants and their families and contributes substantially to health care costs. Knowing that inflammation is one of the key drivers of BPD, Professor Marcel Nold (Neonatologist and clinician scientist at Monash Newborn) and Associate Professor Claudia Nold are investigating existing anti-inflammatory medications, approved for use in children, that could be used as a preventative treatment to protect babies from developing BPD.

Team | Professor Marcel Nold, Professor Claudia Nold, Dr Ina Rudloff, Dr Christine Bui

Long term outcomes of amnion cell therapy for BPD in premature babies

Bronchopulmonary dysplasia (BPD) collaborators

Support for people with bronchopulmonary dysplasia (BPD)

Our scientists cannot provide medical advice.
If you would like to find out more information about bronchopulmonary dysplasia, please visit

Share this page